A multi-office team assisted our client Aptorum Group with its cross-listing on the Euronext Paris exchange. Aptorum, a biopharmaceutical company based in Hong Kong, is focused on the development of novel therapeutics to address global unmet medical needs.

Related Professionals: Gerard S. DiFiore Guilain Hippolyte Lucie Guegan James F. Wilkinson Fiona McFarlane Sheran Sharafi

The cross-listing covers its Class A Ordinary Shares (the same class as listed on Nasdaq). The shares will be traded on the Professional Compartment of Euronext in Paris, with trading expected to commence on July 24, 2020. The company did not issue any additional shares. Aptorum is believed to be the first biotech company to have achieved this sort of cross-listing. 

About Reed Smith

Reed Smith is a dynamic international law firm dedicated to helping clients move their businesses forward. Our belief is that by delivering smarter and more creative legal services, we will not only enrich our clients’ experiences with us, but also support them in achieving their business goals.

Our long-standing relationships, international outlook, and collaborative structure make us the go-to partner for the speedy resolution of complex disputes, transactions, and regulatory matters.

For further information, please visit reedsmith.com.